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The development of diabetes-related microvascular com-
plications in type 1 diabetes (T1DM) is known to be
related to glycaemic control, but the degree to which var-
iations in HbA1c across the lifetime contributes to this
risk is unknown. Our hypothesis was that individuals
with poor control in childhood and subsequent improved
control in adulthood would still have an increased risk of
severe diabetes-related complications when compared
with individuals who achieved good control throughout
the lifecourse. This study aimed to investigate this pre-
mise in a cohort for whom serial lifetime glycaemic data
are available. The study population comprised children
diagnosed with T1DM <18 years at The Royal Children’s
Hospital (Melbourne) who transitioned to the Royal Mel-
bourne Hospital for ongoing (adulthood) care. Data were
collected through BioGrid Australia, a biorepository
allowing inter-institutional data linkage, and included
demographics as well as serial HbA1c and complication
data. ‘Severe complications’ were defined as severe dia-
betes-related eye disease, renal failure, ulceration/ampu-
tation or death. Glycaemic control was categorised
according to HbA1c changes over time, based on median
values throughout the lifecourse; “Optimal” (≤8.2%
throughout lifecourse), “Improving” (>8.2% in childhood,
≤8.2% in adulthood), “Worsening” (≤8.2% in childhood,
>8.2% in adulthood), “Poor” (>8.2% throughout life-
course). A total of 503 (male=253) individuals were iden-
tified, diagnosed 1975-2010. At the time of follow up,
mean (SD) age was 27.9 (6.2) years and median (IQR)
duration of diabetes was 17.8 (12.2, 23.2) years. Severe
complications were documented in 26 (5.2%) and were
associated with mean HbA1c at age 16-30 years (<0.05)
and intra-individual lifetime glycaemic variability
expressed as HbA1cSD (p=0.02). The relative risk (95%
confidence interval) of developing severe complications
in the improving, worsening and poor groups was
14.9 (1.7-130.9, p=0.01, n=50), 12.5 (1.4-109.4, p <0.01,
n=60) and 15.4 (2.1-114.8, p <0.01, n=206) respectively
when compared to the optimal group (n=187). In conclu-
sion, the overall rate of severe complications is low in
this cohort despite the lifecourse poor glycaemic control
demonstrated in 40.1%. Our findings demonstrate that
poor glycaemic control in childhood has a lasting effect
on the development of severe microvascular complica-
tions in adulthood.
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